| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +13% |
| 3Y CAGR | +10% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +57% |
| 3Y CAGR | +65% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,694.70 -9.10 (0.19%) | 21,500.75 | 29.25 | 5.12 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,560.50 +43.30 (1.72%) | 19,125.30 | 28.21 | 5.33 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,042.00 -64.50 (0.91%) | 17,765.63 | 104.73 | 20.35 | ||
Natco PharmaNATCOPHARM | ₹849.80 -4.00 (0.47%) | 15,284.34 | 13.35 | 1.66 |